Kaiser Foundation Health Plan Northern California
Blenrep (belantamab mafodotin-blmf)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Multiple Myeloma:
    Documented Diagnosis: Yes
    Age Requirement: >= 18

  • Multiple Myeloma:
    Age Requirement: >= 18
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Drug Policy Based On: Payer Specific
    ECOG Score Requirement in Policy: N/A
    ECOG status <=2: No
    Diagnosis Types: Adult patients with relapsed or refractory multiple myeloma